Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    1728930 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed The SILVER Study: Systolic Hypertension Interaction With Left Ventricular Remodeling
Conditions: Hypertension;   Hypertrophy, Left Ventricular
Intervention: Drug: ALT-711
2 Completed The SAPPHIRE Study (Systolic And Pulse Pressure Hemodynamic Improvement By Restoring Elasticity)
Condition: Hypertension
Intervention: Drug: ALT-711
3 Completed Multiple Risk Factor Intervention Trial for the Prevention of Coronary Heart Disease (MRFIT)
Conditions: Cardiovascular Diseases;   Coronary Disease;   Heart Diseases;   Myocardial Ischemia
Interventions: Drug: antihypertensive agents;   Behavioral: smoking cessation;   Behavioral: diet, fat-restricted;   Drug: diuretics
4 Terminated Systolic Pressure Efficacy and Safety Trial of Alagebrium (SPECTRA)
Condition: Hypertension
Intervention: Drug: alagebrium chloride (ALT-711)
5 Completed Mortality Surveillance of MRFIT Screenees
Conditions: Cardiovascular Diseases;   Heart Diseases;   Cerebrovascular Accident;   Coronary Disease;   Hypertension;   Cardiomyopathy, Congestive
Intervention:

Indicates status has not been verified in more than two years